DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Hensley ML, Enserro D, Hatcher H. et al.
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.
J Clin Oncol 2018;
DOI: 10.1200/JCO.18.00454.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.